HOME › DRUGS › LAMIVUDINE;RALTEGRAVIR POTASSIUM
ACTIVE SUBSTANCE / INN

LAMIVUDINE;RALTEGRAVIR POTASSIUM

Brand name(s): Dutrebis
EMA LISTED
WITHDRAWN
HIV Infections
ACTIVE SUBSTANCE
Lamivudine;Raltegravir Potassium
REGULATORS
EMA
SPONSORS / MAH
Merck Sharp Dohme Limited
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DutrebisMerck Sharp Dohme LimitedWithdrawn26/03/2015HIV Infections

FULL INTELLIGENCE ON LAMIVUDINE;RALTEGRAVIR POTASSIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →